surmount studies tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide after intensive lifestyle intervention

The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according to a new study led by UCLs Professor John Deanfield.

142 adults with T1D and obesity (mean BMI 37.4) started on tirzepatide vs 50 age, sex, and BMI matched controls, followed 12 months

I genuinely believe that health authorities and regulators should step in immediately to stop this and ensure responsible access through licensed practitioners only

PlexusDx connects patients to prescription semaglutide injections starting at $149 per month across all 50 states